Bacteriologic Findings Associated with Chronic Bacterial Maxillary Sinusitis in Adults
|
|
- Isabella Sparks
- 6 years ago
- Views:
Transcription
1 MAJOR ARTICLE Bacteriologic Findings Associated with Chronic Bacterial Maxillary Sinusitis in Adults S. M. Finegold, 1 M. J. Flynn, 1 F. V. Rose, 2 H. Jousimies-Somer, 1 C. Jakielaszek, 2 M. McTeague, 1 H. M. Wexler, 1 E. Berkowitz, 2 and B. Wynne 2 1 Veterans Affairs Medical Center West Los Angeles and University of California, Los Angeles, School of Medicine; and 2 GlaxoSmithKline Pharmaceuticals, Collegeville, Pennsylvania An open-label, multicenter study was performed to assess bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Seventy aerobic (52.2%) and 64 anaerobic (47.8%) pathogens were recovered from clinically evaluable patients at baseline (before therapy). The most commonly isolated anaerobes were Prevotella species (31.1%), anaerobic streptococci (21.9%), and Fusobacterium species (15.6%). The aerobes most frequently recovered included Streptococcus species (21.4%), Haemophilus influenzae (15.7%), Pseudomonas aeruginosa (15.7%), and Staphylococcus aureus and Moraxella catarrhalis (10.0% each). Recurrences of signs or symptoms of bacterial maxillary sinusitis associated with anaerobes were twice as frequent as were those associated with aerobes when counts of anaerobes were 10 3 cfu/ml. A pathogenic role for Granulicatella species in cases of chronic sinusitis was documented for the first time. Chronic sinusitis is one of the most common bacterial infections among adults [1]. Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis have been the predominant aerobic pathogens recovered from patients with acute maxillary sinusitis. When sinusitis becomes chronic, however, these organisms are replaced by a wider variety of both aerobes and anaerobes, and anaerobes play a significant role [2 4]. Special techniques are required for specimen collection and transport and for cultivation of anaerobes [5 7]. Accordingly, reliable data on anaerobic pathogens associated with nonacute sinusitis in adults are limited. Anaerobic streptococci and Prevotella and Fusobacterium species have been identified as predomi- nant anaerobes isolated in previous studies of sinusitis [3, 7 10], but the small sample sizes in these studies and the differences in the collection, transport, and cultivation techniques used have limited the reliability of these data. Detailed bacteriologic data would permit targeted empiric therapy. For example, if Pseudomonas aeruginosa or Staphylococcus aureus were found in the initial specimen, specific coverage would likely be important. Therapy should be adequate to cover b-lactamase producing anaerobes. In the present study, we also assessed the efficacy of amoxicillin/clavulanate for the treatment of chronic bacterial maxillary sinusitis in adults. However, only the findings of bacteriologic studies are reported here. Received 19 November 2001; revised 1 April 2002; electronically published 24 July Financial support: grant from SmithKline Beecham Pharmaceuticals (Collegeville, PA) and VA Merit Review research funds. Reprints or correspondence: Dr. Sydney M. Finegold, Infectious Diseases Section (111 F), VA Medical Center West Los Angeles, Wilshire Blvd., Los Angeles, CA (sidfinegol@aol.com). Clinical Infectious Diseases 2002; 35: by the Infectious Diseases Society of America. All rights reserved /2002/ $15.00 PATIENTS, MATERIALS, AND METHODS Patients. Patient enrollment criteria included age 18 years and a clinical diagnosis of either chronic sinusitis (defined by the presence of symptoms for 6 weeks) or acute exacerbation of chronic sinusitis. Unfortunately, although many patients had their condition classified as chronic sinusitis, the condition of others was simply called sinusitis, and still other patients had 428 CID 2002:35 (15 August) Finegold et al.
2 conditions that were not classified at all by the participating centers. Patients also were required to have abnormal findings (opacification, air-fluid level, or mucosal thickening of 5.0 mm in the affected sinus) on a coronal CT scan and to meet (a) at least 2 major criteria (postnasal discharge, rhinorrhea, facial pain, facial congestion and/or fullness, nasal obstruction and/or blockage, or nasal cavity purulence), or (b) 1 major criterion and 2 minor criteria (tooth pain, earache, headache, sore throat, cough, halitosis, increased wheezing, an oral temperature of 37.8 C, or fatigue). This multicenter study was approved by the institutional review board at each of the participating centers (for a list of investigators and participating centers, please see the Investigators at Participating Centers section that follows the text). Written and verbal informed consent was provided by patients. Bacteriologic investigation. Specimens were obtained by antral puncture of the canine fossa or the lateral nasal cavity wall. Specimens were aspirated by use of a syringe, with instillation of nonbacteriostatic saline done if necessary. Sinus aspirates were injected into anaerobic transport vials (Anaerobe Systems) and were shipped by overnight courier to the Wadsworth Anaerobic Bacteriology Research Laboratory (Los Angeles). Quantitative culture and identification of organisms were done as described elsewhere [11, 12]. Susceptibility testing of isolates with amoxicillin, amoxicillin/ clavulanate, ampicillin, cefuroxime, ciprofloxacin, clarithromycin, and penicillin was done by use of the serial 2-fold agardilution procedure of the National Committee for Clinical Laboratory Standards (NCCLS) [13, 14]. Interpretation. icity was determined using the following criteria: established pathogenicity of the organism, including production of toxins and/or other virulence factors, and dominance of the organism in the infecting flora ( 10 3 cfu/ml). Possible presence of the organism in the normal flora, according to the route of sinus puncture, was also considered. Response to amoxicillin/clavulanate was judged at the end of therapy and at a follow-up visit 3 4 weeks after treatment. Bacteriological eradication was presumed if clinical success was noted and if posttreatment antral puncture was not indicated. RESULTS Bacteriologic findings. A total of 150 (78.9%) of 190 patients completed the study. Bacterial isolates were recovered from 114 (76%) of 150 patients; of 176 organisms isolated, 134 (from 82 patients) were considered pathogens. The average number of organisms isolated per patient was 2.1. Specimens were collected from the canine fossa of 44 patients (53.7%), from the nasal cavity of 37 patients (45.1%), and by an unknown puncture route in 1 patient (1.2%). Of the 134 pathogens, 70 were aerobic and/or facultative and 64 were anaerobes. Most infections were mixed ( n p 39), and infections due to aerobic pathogens only ( n p 36) were more prevalent than infections due to anaerobic pathogens only ( n p 7). Twenty-nine anaerobic species that belonged to 15 genera and 20 aerobic species that belonged to 14 genera were found. Only 1 pathogen was isolated from each of 34 patients (41.5% of 82 patients); 31 of these pathogens were aerobes and 3 were anaerobes (table 1). M. catarrhalis was the most prevalent ( n p 7). The most prevalent anaerobic pathogens (table 2) were Prevotella species ( n p 20), anaerobic streptococci (originally in the genus Peptostreptococcus; n p 14), and Fusobacterium spe- cies ( n p 10). The most prevalent aerobes (table 3) were Strep- tococcus species ( n p 15), Haemophilus species ( n p 11), P. aeruginosa ( n p 11), S. aureus ( n p 7), and M. catarrhalis ( n p 7). Forty of 64 anaerobes were isolated via the canine fossa (table 2), whereas distribution of aerobes was comparable regardless of route of puncture (table 3). Organisms were presumed to be eradicated if a patient showed clinical improvement or was Table 1. Single pathogens isolated from antral sinus puncture specimens obtained from patients with chronic bacterial maxillary sinusitis at baseline. No. isolated Anaerobic Actinomyces gerensceriae 1 Actinomyces viscosus 1 Prevotella melaninogenica 1 Total 3 Aerobic Granulicatella adiacens a 1 Granulicatella elegans a 2 Haemophilus influenzae 3 Moraxella catarrhalis 7 Pseudomonas aeruginosa b 3 Staphylococcus aureus 4 Stenotrophomonas maltophilia 2 Streptococcus pneumoniae 2 Other c 7 Total 31 a Although the pathogenicity of this organism in patients with chronic bacterial maxillary sinusitis has not been established, the organism was isolated as a single pathogen with a count 5 of 10 cfu/ml. b One patient had 3 isolates of P. aeruginosa only, and 2 other patients had 2 different P. aeruginosa isolates only. c Includes 1 each of Enterobacter agglomerans, Escherichia coli, Haemophilus parainfluenzae, Morganella morganii, Pasteurella multocida (no known animal contact), Proteus mirabilis, and group A Streptococcus. Bacteriologic Findings for Sinusitis CID 2002:35 (15 August) 429
3 Table 2. Distribution of 64 anaerobic pathogens recovered from patients with chronic bacterial maxillary sinusitis at baseline, by route of sinus puncture. No. of isolates recovered, by route of sinus puncture Canine fossa Nasal cavity Total no. (%) of isolates Prevotella species (31.3) P. melaninogenica a (7.8) P. intermedia/nigrescens (6.3) P. oris (6.3) P. buccae (3.1) P. oralis (1.6) P. heparinolytica (1.6) P. loescheii (1.6) P. tannerae (1.6) Other (1.6) Anaerobic streptococcal species (21.9) Micromonas micros b (14.1) Finegoldia magna b (3.1) Peptostreptococcus anaerobius (3.1) Anaerococcus prevotii b (1.6) Fusobacterium species (15.6) F. nucleatum (14.1) F. necrophorum (1.6) Actinomyces species (6.3) A. viscosus (3.1) A. gerensceriae (1.6) A. odontolyticus (1.6) Capnocytophaga species (4.7) C. sputigena (1.6) Other (3.1) Dialister pneumosintes (4.7) Eubacterium species (4.7) E. lentum (1.6) E. nodatum (1.6) Other (1.6) Gemella species (4.7) G. morbillorum (3.1) Other (1.6) Bifidobacterium dentium (1.6) Clostridium species (1.6) Eikenella corrodens (1.6) Porphyromonas gingivalis (1.6) Total, no. (%) 40 (62.5) 24 (37.5) 64 (100.0) c a Includes Prevotella melaninogenica/denticola ( ). n p 1 b Formerly called Peptostreptococcus species. c Actual percentage was rounded down (from 100.3%).
4 Table 3. Distribution of 70 aerobic or facultative pathogens recovered from patients with bacterial maxillary sinusitis at baseline, by route of sinus puncture. No. of isolates recovered, by route of sinus puncture Canine fossa Nasal cavity Total no. (%) of isolates Pseudomonas aeruginosa (15.7) Haemophilus influenzae (15.7) Moraxella catarrhalis (10.0) Staphylococcus aureus (10.0) Haemophilus parainfluenzae (5.7) Streptococcus species (21.4) S. intermedius a (7.1) S. constellatus a (5.7) S. pneumoniae (5.7) Group A (2.9) Enterobacter species (4.3) E. agglomerans (2.9) E. aerogenes (1.4) Granulicatella species (4.3) G. elegans (2.9) G. adiacens (1.4) Stenotrophomonas maltophilia (4.3) Citrobacter freundii (1.4) Escherichia coli (1.4) Klebsiella ozaenae (1.4) Morganella morganii (1.4) Pasteurella multocida (1.4) Proteus mirabilis (1.4) Total, no. (%) 34 (48.6) 36 (51.4) 70 (100.0) b a These organisms are classified as aerobes, but they grow better if specimens are transported and cultured anaerobically. b Actual percentage was rounded up (from 98.8%). cured; 124 pathogens were presumed to be eradicated by the end of therapy, and 110 were still presumed to be eradicated at follow-up. Of the 24 pathogens presumed not to be eradicated at follow-up, 6 were associated with treatment failure at the end of therapy and 9 were associated with recurrence of signs or symptoms of bacterial maxillary sinusitis at follow-up. Aerobes ( n p 6) were more commonly associated with treat- ment failure at the end of therapy, whereas anaerobes ( n p 9) were more often associated with recurrence of signs or symptoms of bacterial maxillary sinusitis at follow-up (table 4). P. aeruginosa ( n p 3) and S. aureus ( n p 2) were the principal pathogens associated with clinical failure at the end of therapy. In contrast, Prevotella species ( n p 3) and H. influenzae ( n p 2) were associated with recurrence at follow-up. In addition to the definite pathogens isolated in this study, 42 other organisms were considered not significant (on the basis of low counts of colony-forming units and the probability that they were part of the normal flora). Granulicatella adiacens, which was not previously considered pathogenic in association with bacterial maxillary sinusitis, was found to be the only isolate (count, 10 5 cfu/ml) recovered from 1 patient who had clinical failure at the end of therapy. G. adiacens ( n p 1) and Granulicatella elegans ( n p 2) were also classified as pathogens in 3 other patients because they were present as single isolates with counts of 10 5 cfu/ml. Antimicrobial susceptibility of bacterial isolates. Susceptibility testing of isolates with amoxicillin/clavulanate was performed on 94 of 134 pathogens (52 aerobes and 42 anaerobes; 70.1%) from 65 patients. Forty-one anaerobes and 38 aerobes had an MIC of 1 mg/ml. A single anaerobe (Prevotella intermedia/nigrescens) had an MIC of 8 mg/ml, and 5 different aerobes (P. aeruginosa [9 strains]; Stenotrophomonas maltophilia [2 strains]; and Enterobacter aerogenes, H. influenzae, and Morganella morganii [1 strain each]) had MICs of 32 mg/ml. There were no NCCLS-determined amoxicillin/clavulanate breakpoints for P. aeruginosa, the aerobic pathogen most associated with an MIC of 32 mg/ml in the present study, or for S. maltophilia, another aerobic pathogen associated with an MIC of 32 mg/ml in the present study. Clearly, however, these organisms must be considered resistant. Correlation was poor between MICs of amoxicillin/clavulanate and clinical failure at the end of therapy; 1 of 4 patients had resistant isolates, 2 of 4 had susceptible isolates, and isolates recovered from the remaining patient were not tested. Similarly, of the 8 patients with recurrence of signs or symptoms of chronic bacterial maxillary sinusitis at follow-up, 1 had resistant organisms, 1 had an organism with intermediate resistance, and 6 had susceptible organisms only. Thirty-six patients received antibiotics before study enrollment. This did not correlate with high MICs of amoxicillin/ clavulanate. Penicillin G and ampicillin showed poor activity against staphylococci; one-half to two-thirds of such isolates were resistant to these agents. Prevotella species also showed 50% resistance to these drugs. Thirty-eight of 91 streptococcal isolates, including 2 of 6 S. pneumoniae isolates, were resistant to clarithromycin, and 10 of 15 Haemophilus strains showed intermediate resistance to this agent. A total of 28 of 30 staphylococcal isolates and all 16 Haemophilus isolates evaluated were susceptible to ciprofloxacin. One of 6 S. pneumoniae isolates was resistant to cefuroxime, and 1 of 6 such isolates had intermediate resistance to the agent. DISCUSSION The present study was unique in that it provided quantitation of bacteriologic data, analysis of likely pathogenicity of organ- Bacteriologic Findings for Sinusitis CID 2002:35 (15 August) 431
5 Table 4. s associated with clinical failure at the end of therapy (in 4 patients) or recurrence of signs or symptoms of chronic bacterial maxillary sinusitis (in 8 patients). No. of pathogens associated with Clinical failure at end of therapy (n p 10) Recurrence at follow-up (n p 14) Total no. of pathogens (n p 24) Aerobic Granulicatella adiacens Haemophilus influenzae Moraxella catarrhalis Pseudomonas aeruginosa Staphylococcus aureus Stenotrophomonas maltophilia Anaerobic Bifidobacterium dentium Dialister pneumosintes Fusobacterium nucleatum Gemella morbillorum Micromonas micros Prevotella intermedia/nigrescens Prevotella melaninogenica/denticola Streptococcus constellatus a a This organism is classified as an aerobe, but it grows better if specimens are transported and cultured anaerobically. isms, detailed identification (with up-to-date terminology) of anaerobic and aerobic and/or facultative organisms involved in chronic bacterial maxillary sinusitis, and correlation of bacteriologic findings with clinical failure. Two different routes of antral sinus puncture were compared. Although the association of anaerobes with chronic sinusitis has been reported for many years, the role of such pathogens has not been well understood as a result, in part, of the polymicrobial nature of chronic sinusitis. Previous studies that have evaluated sinus puncture aspirates obtained from patients with chronic sinusitis have yielded mixed findings varying from an absence of anaerobes to anaerobes constituting 56% of all pathogens isolated [3, 4, 7 10]. In studies that used good anaerobic techniques, anaerobes accounted for 25% 56% of isolates [2, 3, 8, 9]. Anaerobes accounted for 48% of the pathogens isolated in the present study. Prevotella species, anaerobic streptococci, and Fusobacterium species accounted for 75% of anaerobic pathogens isolated in the present study, a finding consistent with results of other studies [2 4, 7 10]. Goldstein et al. [15] reported selected antimicrobial susceptibilities of a large number of aerobic ( n p 207) and anaerobic ( n p 162) pathogens iso- lated from antral sinus puncture specimens (type not stated) during They noted a diversity of aerobic and anaerobic bacteria, a finding similar to that of our study. There is no information as to whether the cases of sinusitis in their study were acute or not, and no other clinical data were presented. The distribution of aerobic and/or facultative organisms in the present study was consistent with that seen in other studies of chronic sinusitis. Streptococcus species (21.4%), H. influenzae (15.7%), and M. catarrhalis (10.0%) were among the most frequently isolated aerobic and/or facultative pathogens. Furthermore, consistent with findings of other published studies [3, 4, 7 10], a wide variety of other aerobes and/or facultative pathogens were also recovered (of all such pathogens, 15.7% were P. aeruginosa, 10.0% were S. aureus, and 7.1% were Streptococcus intermedius). The present study indicates that G. adiacens and G. elegans play a significant pathogenic role in chronic bacterial maxillary sinusitis and may account for treatment failure. INVESTIGATORS AT PARTICIPATING CENTERS The investigators (participating centers and/or locations) were Jack Anon (Erie, PA), Stuart Bentkover (Fallon Clinic; Worcester MA), Don Brandon (California Research Foundation; San Diego), Itzhak Brook (Washington, DC), Herbert Daniels 432 CID 2002:35 (15 August) Finegold et al.
6 (Heart of America Research Institute; Mission, KS), B. J. Ferguson (The Eye and Ear Institute; Pittsburgh, PA), Michael Friedman (Chicago), Trevor Ian Goldberg (Charlotte Eye, Ear, Nose, and Throat Associates; Charlotte, NC), Jeffery Hausfeld (Bethesda, MD), Neil Kassman (Statesville Medical Group; Statesville, NC), James McCarty (Hilltop Research; Fresno, CA), Thomas Newbill (Richmond, VA), Michael Poole (University of Texas Medical School at Houston), Donald Pulver (AAIR Research Center; Rochester, NY), Richard Robins (Newport News, VA), Albert Roper (Norfolk, VA), Joram Seggev (Las Vegas, NV), Alan Shikani (The Good Samaritan Hospital; Baltimore, MD), James Stankiewicz (Loyola University Medical Center; Maywood, IL), Richard E. Sterling (Carolina Research; Orangeburg, SC), Brantley Sydnor (Roanoke Ear, Nose, and Throat Clinic; Roanoke, VA), and Kevin J. Wingert (Sierra Medical Research; Fresno, CA). Acknowledgment We would like to thank the investigators at the participating centers who participated in and made specimens from their patients available for this study. References 1. Benson V, Marano MA. Current estimates from the National Health Interview Survey, Vital Health Stat 1998; series 10(199): Nord CE. The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis. Clin Infect Dis 1995; 20: Brook I, Frazier EH, Foote PA. Microbiology of chronic maxillary sinusitis: comparison between specimens obtained by sinus endoscopy and by surgical drainage. J Med Microbiol 1997; 46: Brook I, Frazier EH, Foote PA. Microbiology of the transition from acute to chronic maxillary sinusitis. J Med Microbiol 1996; 45: Finegold SM. Anaerobic bacteria: general concepts. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 5th ed, vol 2. Philadelphia: Churchill Livingstone, 2000: Finegold SM. Overview of clinically important anaerobes. Clin Infect Dis 1995; 20(Suppl 2):S Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 1998; 316: van Cauwenberge PB, Ingels KJAO, Bachert C, Wang DY. Microbiology of chronic sinusitis. Acta Otorhinolaryngol Belg 1997; 51: Brook I. Bacteriology of chronic maxillary sinusitis in adults. Ann Otol Rhinol Laryngol 1989; 98: Biel MA, Brown CA, Levinson RM, et al. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1998; 107: Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 7th ed. Washington, DC: ASM Press, Summanen P, Baron EJ, Citron DM, et al. Wadsworth anaerobic bacteriology manual. 5th ed. Belmont, CA: Star Publishing, National Committee for Clinical Laboratory Standards (NCCLS). NCCLS performance standards for antimicrobial disk susceptibility tests, approved standard. 6th ed. NCCLS Document M2-A6. Wayne, PA: NCCLS, 1997:vol. 17, no National Committee for Clinical Laboratory Standards (NCCLS). Methods for antimicrobial susceptibility testing of anaerobic bacteria, approved standard. 4th ed. NCCLS Publication M11-A4. Wayne, PA: NCCLS, 1997:vol. 17, no Goldstein EJC, Citron DM, Merriam CV. Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis. Antimicrob Agents Chemother 1999; 43: Bacteriologic Findings for Sinusitis CID 2002:35 (15 August) 433
Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis
Journal of Medical Microbiology (2004), 53, 879 885 DOI 10.1099/jmm.0.45655-0 Short Communication Correspondence Itzhak Brook ib6@georgetown.edu Received 1 March 2004 Accepted 18 May 2004 Discrepancies
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationReceived 30 May 2004/Returned for modification 31 August 2004/Accepted 25 September 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2005, p. 408 413 Vol. 49, No. 1 0066-4804/05/$08.00 0 doi:10.1128/aac.49.1.408 413.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationCefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the
More informationCell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis
Key words Sample Cell counting (EtBr) DNA extraction Cell-lysis by 3% SDS beads beating Before cell-lysis After cell-lysis Cell-lysis efficiency (Maintained70%) PCR PCR amplification of partial fragments
More informationAcute bacterial rhinosinusitis: new aspects regarding bacterial spectrum and microbiologic diagnosis
Romanian Journal of Rhinology, Vol. 4, No. 14, April-June 2014 ORIGINAL STUDY Acute bacterial rhinosinusitis: new aspects regarding bacterial spectrum and microbiologic diagnosis Iulia Sabaru, Amalia Neagu
More informationAssessment Of Different Strengths Of Levofloxacin In The Treatment Of Acute Bacterial Sinusitis
Science Journal of Medicine & Clinical Trial ISSN: 2276-7487 http://www.sjpub.org/sjmct.html Author(s) 2013. CC Attribution 3.0 License. Research Article Published By Science Journal Publication Volume
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL (A) Further inclusion criteria and categorisation of ICD-10 diagnostic codes Pneumonia: A310 Pulmonary mycobacterial infection A420 Pulmonary actinomycosis A481 Legionnaires' disease
More informationNormal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine
Normal Human Flora (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine 2014-2015 Objectives Describe important human normal flora. Demonstrate the epidemiology of human normal flora. Determine
More informationOptimizing MALDI-TOF Use. Clinical Impact Laboratory Impact
Optimizing MALDI-TOF Use Clinical Impact Laboratory Impact Christine C. Ginocchio, PhD, MT (ASCP) Clinical Professor of Medicine Hofstra North Shore-LIJ School of Medicine, NY VP, Global Microbiology Affairs,
More informationThis is a repository copy of The microbial causes of complicated Acute Bacterial Rhinosinusitis and implications for empirical antimicrobial therapy.
This is a repository copy of The microbial causes of complicated Acute Bacterial Rhinosinusitis and implications for empirical antimicrobial therapy. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/92131/
More informationUPPER RESPIRATORY TRACT INFECTIONS. IAP UG Teaching slides
UPPER RESPIRATORY TRACT INFECTIONS 1 INTRODUCTION Most common problem in children below 5 years. In this age group they get about 6 8 episodes per year. It includes infections of nasal cavity, throat,
More informationMaterials and Methods: Literature review and Authors opinion.
Haffajee AD, Bogren A, Hasturk H et al. Subgingival microbiota of chronic periodontitis subjects from different geographic locations. J Clin Periodontol 2004; 31:996-1002. Purpose: To compare the subgingival
More informationDIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05
Date company submitted: 15 Dec 04 Date received by CDER: 15 Dec 04 Reviewer: Fred Marsik, Ph.D. Date assigned: 15 Dec 04 NAME AND ADDRESS OF APPLICANT Wyeth Pharmaceuticals Inc. P.O. Box 8299 Philadelphia,
More informationUpper Respiratory Tract Infections / 42
Upper Respiratory Tract Infections 1 Upper Respiratory Tract Infections Acute tonsillitispharyngitis Acute otitis media Acute sinusitis Common cold Acute laryngitis Otitis externa Mastoiditis Acute apiglottis
More informationConsultation on the Revision of Carbapenem Breakpoints
Consultation on the Revision of Carbapenem Breakpoints July 2018 Please send comments to the EUCAST Scientific Secretary at jturnidge@gmail.com by September 15. EUCAST revision of carbapenem breakpoints
More informationBacterial composition in the supragingival plaques of children with and without dental caries
182 Ro kiewicz D, et al. Advances in Medical Sciences Vol. 51 2006 Suppl. 1 Bacterial composition in the supragingival plaques of children with and without dental caries Ro kiewicz D 1, Daniluk T 2, Zaremba
More informationZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg
ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized
More informationAn Open Multicenter Study of the Use of Gatifloxacin for the Treatment of Non- Complicated Acute Bacterial Rhinosinusitis in Adults
162 BJID 2005; 9 (April) An Open Multicenter Study of the Use of Gatifloxacin for the Treatment of Non- Complicated Acute Bacterial Rhinosinusitis in Adults Weckx L.L.M. 1, Campos C.A.H. 2, Sakano E. 3,
More informationStreptococci facultative anaerobe
THE GENUS STREPTOCOCCUS The genus Streptococcus obtains Gram-positive cocci, nonmotile, nonsporeforming, arranged mostly in chains or in pairs. Most species are facultative anaerobes. Some of streptococci
More informationRespiratory tract infections. Krzysztof Buczkowski
Respiratory tract infections Krzysztof Buczkowski Etiology Viruses Rhinoviruses Adenoviruses Coronaviruses Influenza and Parainfluenza Viruses Respiratory Syncitial Viruses Enteroviruses Etiology Bacteria
More informationBacteriological Findings of Acute Maxillary Sinusitis in Young Adults
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1988, p. 1919-1925 0095-1137/88/101919-07$02.00/0 Copyright C 1988, American Society for Microbiology Vol. 26. No. 10 Bacteriological Findings of Acute Maxillary
More informationComparative In Vitro Activities of Ertapenem (MK-0826) against 469 Less Frequently Identified Anaerobes Isolated from Human Infections
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2002, p. 1136 1140 Vol. 46, No. 4 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.4.1136 1140.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationStudy of Nasal Mucosal Flora in Acute and Chronic Sinusitis
Study of Nasal Mucosal Flora in Acute and Chronic Sinusitis Rupeshkumar TS 1, Rajesh K 2, Prabhusaran N 3*, Jesudoss A 4 Original Research Article 1MBBS Student, 2Associate Professor, 4 Professor & Head,
More informationSuperbugs in Dental Practice: A Narrative Review
Anushka Gupta, Nagesh Lakshminarayan REVIEW ARTICLE 10.00/jpjournals... 1 Anushka Gupta, 2 Nagesh Lakshminarayan ABSTRACT Microbes do undergo perpetual mutations, thus they evolve swiftly. This may have
More informationdoi:
Nig. J. Pure &Appl. Sci. Vol. 30 (Issue 1, 2017) ISSN 0794-0378 (C) 2017 Faculty of Physical Sciences and Faculty of Life Sciences, Univ. of Ilorin, Nigeria www.njpas.com.ng doi: http://dx.doi.org/10.19240/njpas.2017.a10
More informationSupplemental Digital Content
Rapid Diagnosis of Infection in the Critically Ill (RADICAL), a multicenter study of molecular detection in bloodstream infections, pneumonia and sterile site infections Jean-Louis Vincent, David Brealey,
More informationActivity of Ceftolozane/Tazobactam Against a Broad Spectrum of Recent Clinical Anaerobic Isolates
AAC Accepts, published online ahead of print on 25 November 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.02253-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. Activity
More informationMicrobial DNA qpcr Array Oral Disease
Microbial DNA qpcr Array Oral Disease Cat. no. 330261 BAID-1904ZRA For real-time PCR-based, application-specific microbial identification or profiling The Oral Disease Microbial DNA qpcr Array is a research
More informationMicrobiology of Sinusitis
Microbiology of Sinusitis Itzhak Brook 1 1 Georgetown University School of Medicine, Washington DC Most sinus infections are viral, and only a small proportion develops a secondary bacterial infection.
More informationReceived 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005
Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,
More informationThe Bacteriology of Bronchiectasis in Australian Indigenous children
The Bacteriology of Bronchiectasis in Australian Indigenous children Kim Hare, Amanda Leach, Peter Morris, Heidi Smith-Vaughan, Anne Chang Presentation outline What is bronchiectasis? Our research at Menzies
More information27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite
8 «Evidence-based Medicine-» 27/11/2012,,,, : :,,,,,,,, (30%-50%) () (5%-10%) (40%-50%) 20% Infuenza A B Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila
More informationFamily Practice Vol. 18, No. 3 Oxford University Press 2001 Printed in Great Britain
Family Practice Vol. 18, No. 3 Oxford University Press 2001 Printed in Great Britain The prevalence of potential pathogenic bacteria in nasopharyngeal samples from individuals with a respiratory tract
More informationChoosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens
Choosing an appropriate antimicrobial agent Consider: 1) the host 2) the site of infection 3) the spectrum of potential pathogens 4) the likelihood that these pathogens are resistant to antimicrobial agents
More informationClinical Comparison of Cefotaxime with Gentamicin plus Clindamycin in the Treatment of Peritonitis and Other Soft-Tissue Infections
REVIEWS OF INFECTIOUS DISEASES. VOL. 4, SUPPLEMENT. SEPTEMBER-OCTOBER 982 982 by The University of Chicago. All rights reserved. 062-0886/82/0405-022$02.00 Clinical Comparison of with Gentamicin plus Clindamycin
More informationComparative Efficacy and Safety Evaluation of Cefaclor VS Amoxycillin + Clavulanate in Children with Acute Otitis Media (AOM)
Special Article Comparative Efficacy and Safety Evaluation of Cefaclor VS Amoxycillin + Clavulanate in Children with Acute Otitis Media (AOM) Mukesh Aggarwal, Ramanuj Sinha 1, M. Vasudeva Murali 2, Prita
More informationPOLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS
POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: July 2013 Approved by: The Drugs & Therapeutics Committee Date: April 2016 Implementation
More informationRespiratory Infections
Respiratory Infections NISHANT PRASAD, MD THE DR. JAMES J. RAHAL, JR. DIVISION OF INFECTIOUS DISEASES NEWYORK-PRESBYTERIAN QUEENS Disclosures Stockholder: Contrafect Corp., Bristol-Myers Squibb Co Research
More informationReceived 25 November 2002/Returned for modification 14 February 2003/Accepted 11 April 2003
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2003, p. 2770 2774 Vol. 47, No. 9 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.9.2770 2774.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationBacteriological Profile of Chronic Rhino Sinusitis
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 07 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.707.121
More informationRhinosinusitis is a common disorder affecting 35 million
Otolaryngology Head and Neck Surgery (2006) 134, 3-9 ORIGINAL RESEARCH Endoscopically Directed Middle Meatal Cultures Versus Maxillary Sinus Taps in Acute Bacterial Maxillary Rhinosinusitis: A Meta-Analysis
More informationSinusitis ITZHAK BROOK. Anatomy and pathogenesis
Periodontology 2000, Vol. 49, 2009, 126 139 Printed in Singapore. All rights reserved Sinusitis Ó 2009 The Author. Journal compilation Ó 2009 Blackwell Munksgaard PERIODONTOLOGY 2000 ITZHAK BROOK Sinusitis
More informationMonitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 3 June 214 1. The cumulative cases report since December 21 and cases report during April to June 214 During 1 April to 3 June
More informationMANAGEMENT of BACTERIAL RHINOSINUSITIS
MANAGEMENT of BACTERIAL RHINOSINUSITIS Jennifer Le, PharmD Assistant Professor of Pharmacy Practice, College of Pharmacy, Western University of Health Sciences Martin S. Lipsky, MD Dean and Professor of
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS Cefuroxime Axetil Tablets IP 125/250/500mg QUALITATIVE AND QUANTITATIVE COMPOSITION CEFTUM TABLETS 125
More informationStaphylococcus aureus: Is It a Pathogen of Acute Bacterial Sinusitis in Children and Adults?
VIEWPOINTS Staphylococcus aureus: Is It a Pathogen of Acute Bacterial Sinusitis in Children and Adults? Ellen R. Wald Department of Pediatrics, University of Wisconsin, School of Medicine and Public Health,
More informationBabak Valizadeh, DCLS
Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological
More informationCeftizoxime in the treatment of infections in patients with cancer
Journal of Antimicrobial Chemotherapy (98), Suppl. C, 67-73 Ceftizoxime in the treatment of infections in patients with cancer V. Fainstein, R. Bolivar,. Elting, M. Valdivieso and G. P. Bodey Department
More informationTHE USE OF THE PENICILLINASE-RESISTANT
Therapeutic problems THE USE OF THE PENICILLINASE-RESISTANT PENICILLIN IN THE PNEUMONIAS OF CHILDREN MARTHA D. Yow, MARY A. SOUTH AND CHARLES G. HESS From the Department of Pediatrics, Baylor University
More informationNational Surveillance of Nosocomial Septicemia (Hospital-wide)
National Surveillance of Hospital Infections National Surveillance of Nosocomial Septicemia (Hospital-wide) National analysis Data from 01/01/2008 to 31/12/2008 1. SUMMARY BY QUARTER Quarter Patient records
More informationMacroscopic Purulence, Leukocyte Counts, and Bacterial Morphotypes in Relation to Culture Findings for Sinus
JOURNAL OF CLINICAL MICROBIOLOGY, OCt. 1988, p. 1926-1933 0095-1137/88/101926-08$02.00/0 Copyright 1988, American Society for Microbiology Vol. 26, No. 10 Macroscopic Purulence, Leukocyte Counts, and Bacterial
More informationHigh dose amoxicillin for sinusitis
High dose amoxicillin for sinusitis Amoxil ( amoxicillin ) is a commonly used penicillin antibiotic. It is produced in tablets (500 mg 875 mg), capsules, chewable tablets and oral suspensions. 6-3-2018
More informationGeneral Bacteriology 1 and 2. List of samples and the microbes linked to the corresponding photo replies since
External Quality Assessment Scheme General Bacteriology 1 and 2. List of samples and the microbes linked to the corresponding photo replies since 1.1.2008 Microbe Survey/ Sample Specimen type. Patient
More informationORIGINAL ARTICLE. The Bacteriology of Chronic Rhinosinusitis With and Without Nasal Polyps
ORIGINAL ARTICLE The Bacteriology of Chronic Rhinosinusitis With and Without Nasal Polyps Andrea Niederfuhr; Hanspeter Kirsche, MD; Herbert Riechelmann, MD; Nele Wellinghausen, MD Objective: To compare
More informationSkin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease
Skin reactivity to autologous bacteria 149 Original Article Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease J. Halasa 1, M. Halasa
More informationMANAGEMENT OF RHINOSINUSITIS IN ADULTS IN PRIMARY CARE
PROFESSOR DR SALINA HUSAIN DEPUTY HEAD DEPARTMENT OF OTORHINOLARYNGOLOGY-HEAD NECK SURGERY UKM MEDICAL CENTRE MANAGEMENT OF RHINOSINUSITIS IN ADULTS IN PRIMARY CARE CLINICAL PRACTICE GUIDELINES ON MANAGEMENT
More informationManagement of URTI s in Children
Management of URTI s in Children Robin J Green PhD Antibiotics - Dilemmas for General Practitioners Antibiotic overuse = Resistance Delay in antibiotic use = Mortality Patient expectation Employer expectation
More informationUse of Pharmacodynamic End Points in the Evaluation of Gatifloxacin for the Treatment of Acute Maxillary Sinusitis
MAJOR ARTICLE Use of Pharmacodynamic End Points in the Evaluation of Gatifloxacin for the Treatment of Acute Maxillary Sinusitis Paul G. Ambrose, 1,2 Jack B. Anon, 3 Joel S. Owen, 1 Scott Van Wart, 1 Mary
More informationClinical and Microbiological Evaluation of Osteomyelitis
Bahrain Medical Bulletin, Vol.23, No.2, June 2001 Clinical and Microbiological Evaluation of Osteomyelitis Haider Abdul-Lateef Mousa, MBChB, MSc* Thamer A Hamdan, MBChB, FRCS** Sundus S Bakr, BSc, PhD***
More informationStudy showing the major association of obligate anaerobic gram negative bacilli as cause of chronic periodontitis
2019; 5(1): 28-32 ISSN Print: 2394-7489 ISSN Online: 2394-7497 IJADS 2019; 5(1): 28-32 2019 IJADS www.oraljournal.com Received: 11-11-2018 Accepted: 15-12-2018 Dr. Sonal Jindal Assistant Professor, Department
More informationCeftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection)
COMPOSITION Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection) CEFTOMAX - S Injection 1.5 gm Each vial contains: Cefoperazone Sodium equivalent to Cefoperazone IP. 1,000 mg Sulbactam Sodium
More informationAntimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3501 3512 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3501 3512.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationAntibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)
Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336
More informationUniversity of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology
University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational
More informationPOLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS
POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: Date: July 2018 The Drugs & Therapeutics Committee Implementation
More informationJAC Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections
Journal of Antimicrobial Chemotherapy (1998) 41, Suppl. B, 69 73 JAC Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections G. Tatsis*, G.
More informationExpert rules in antimicrobial susceptibility testing: State of the art
Expert rules in antimicrobial susceptibility testing: State of the art ESCMID Postgraduate Education Course Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic Hospital Universitario
More informationINTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES
Upper Respiratory Tract Infections Return to Syllabus INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES General Goal: To know the major mechanisms of defense in the URT, the major mechanisms invaders use
More informationBacteroides Species, and Fusobacterium Species to Newer
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1991, p. 1214-1218 0066-4804/91/061214-05$02.00/0 Copyright 1991, American Society for Microbiology Vol. 35, No. 6 Susceptibilities of 394 Bacteroides fragilis,
More informationOriginal article. Microorganisms Isolated From Foot Ulcers Infection Of Diabetic Iraqi Patients. Summary:
Original article Microorganisms solated From Foot Ulcers nfection Of Diabetic raqi Patients. Ryath shaya AL-Hemedawi *MSc. Suhaila M. AL-Salloum ** PhD Saad S. AL-Azawi*** Ph.D Summary: J Fac Med Baghdad
More informationRESEARCH NOTE. 86 Clinical Microbiology and Infection, Volume 12 Number 1, January 2006
86 Clinical Microbiology and Infection, Volume 12 Number 1, January 2006 REFERENCES 1. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1179 1181. 2. Barenfanger J, Drake
More informationAppropriate Use of Antibiotics for the Treatment of Acute Upper Respiratory Tract Infections in Adults
Appropriate Use of Antibiotics for the Treatment of Acute Upper Respiratory Tract Infections in Adults Kyong Ran Peck, M.D. Division of Infectious Diseases Sungkyunkwan University School of Medicine, Samsung
More informationCHOWDHURY MRA 1, AZAD KAK 2, HOSSAIN MZ 3, SARDAR MH 4, SIDDIQUI MR 5, SAAD S 6, RAHMAN MM 7
ORIGINAL ARTICLES MICROBIAL ASPECT OF ASPIRATION PNEUMONIA IN PATIENTS WITH ALTERED CONSCIOUSNESS ADMITTED IN DHAKA MEDICAL COLLEGE HOSPITAL, BANGLADESH CHOWDHURY MRA 1, AZAD KAK 2, HOSSAIN MZ 3, SARDAR
More informationStudy of etiological factors and sensitivity pattern in CSOM
Indian Journal of Basic and Applied Medical Research; December 2015: Vol.-5, Issue- 1, P. 766-770 766-771 Original article: Study of etiological factors and sensitivity pattern in CSOM Paresh Chavan, G
More informationGeneral Bacteriology 1 (5080) and 2 (5081). List of microbes included in the specimens linked to the corresponding photo replies since
External Quality Assessment Scheme General Bacteriology 1 (5080) and 2 (5081). List of microbes included in the specimens linked to the corresponding photo replies since 1.1.2008. Microbe Round/ Specimen
More informationSteven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2010, p. 2063 2069 Vol. 54, No. 5 0066-4804/10/$12.00 doi:10.1128/aac.01569-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Comparative
More informationPrimaxin IV Injection
Seite 1 von 20 Merck Sharp & Dohme Limited Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU Telephone: +44 (0)1992 467 272 Fax: +44 (0)1992 452 206 Medical Information e-mail: medicalinformationuk@merck.com
More informationReceived 3 April 2008/Returned for modification 5 May 2008/Accepted 17 October 2008
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2009, p. 281 286 Vol. 53, No. 1 0066-4804/09/$08.00 0 doi:10.1128/aac.00441-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Study
More informationChronic rhinosinusitis microbiology studies show the
Rev Bras Otorrinolaringol 2006;72(2):217-22 ORIGINAL ARTICLE Microbiology of the Maxillary and Ethmoid Sinuses in Patients with Chronic Rhinosinusitis Submitted to Functional Endoscopic Sinus Surgery Josiane
More informationSinusitis & its complication. MOHAMMED ALESSA MBBS,FRCSC Assistant Professor,Consultant Otolaryngology, Head & Neck Surgery King Saud University
Sinusitis & its complication MOHAMMED ALESSA MBBS,FRCSC Assistant Professor,Consultant Otolaryngology, Head & Neck Surgery King Saud University Definition Types Clinical manifestation Complications Diagnosis
More informationDisclaimers. Topical Therapy. The Problem. Topical Therapy for Chronic Rhinosinusitis No Disclosures
Topical Therapy for Chronic Rhinosinusitis No Disclosures Disclaimers Off-label use of multiple steroid and antibiotic medications Large talk, limited time Steven D. Pletcher MD University of California,
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory
More information4/7/13 SINUSITIS WHO ARE WE TREATING? AMANDA SAM CONLEY RN, MSN, CFN, LNC, FNP- BC
SINUSITIS WHO ARE WE TREATING? AMANDA SAM CONLEY RN, MSN, CFN, LNC, FNP- BC 1 DefiniGons Anatomy Review Signs and Symptoms OBJECTIVES Acute Viral vrs. Acute Bacterial Treatment Guidelines ANATOMY REVIEW
More informationPRODUCT INFORMATION. Meropenem Kabi powder for intravenous injection or infusion 500 mg 1 g
Meropenem Kabi Powder for Injection NAME OF THE MEDICINE Meropenem, as meropenem trihydrate. PRODUCT INFORMATION The chemical name of meropenem trihydrate is Azabicyclo[3.2.0]hept-2-ene-2- carboxylic acid,
More informationMERREM IV. meropenem PRODUCT INFORMATION COOH CH 3
MERREM IV meropenem PRODUCT INFORMATION NAME OF THE DRUG Meropenem, as meropenem trihydrate. DESCRIPTION Structural Formula: HO H 3 C O COOH H N S H H H H CH 3 H NH CON(CH 3 ) 2. 3H2 O CAS Number: 119478-56-7
More informationDose-dependent effects of tobramycin in an animal model of Pseudomonas sinusitis Am J Rhino Jul-Aug; 21(4):423-7
AMINOGLYCOSIDES Dose-dependent effects of tobramycin in an animal model of Pseudomonas sinusitis Am J Rhino. 2007 Jul-Aug; 21(4):423-7 http://www.ncbi.nlm.nih.gov/pubmed/17882910 Evaluation of the in-vivo
More informationMonitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015 1. The cumulative cases report since December 2010 and cases report during January to March 2015 During
More informationOccurrence of otitis media in children and assessment of treatment options
The Journal of Laryngology & Otology (2015), 129, 779 783. JLO (1984) Limited, 2015 doi:10.1017/s0022215115001127 MAIN ARTICLE Occurrence of otitis media in children and assessment of treatment options
More informationCharacteristics of Streptococcus pseudopneumoniae Isolated from Purulent Sputum Samples
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2006, p. 923 927 Vol. 44, No. 3 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.3.923 927.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Characteristics
More informationDIFFICULT-TO-TREAT CHRONIC
MANAGEMENT STRATEGIES FOR DIFFICULT-TO-TREAT CHRONIC RHINOSINUSITIS DR ZULKEFLI HUSSEIN CONSULTANT EAR NOSE & THROAT SURGEON PANTAI HOSPITAL PENANG DISCLAIMER Nothing to disclose PENANG ISLAND, MALAYSIA
More informationPeriprosthetic Joint Infections due to bacteria from the oral cavity What do we know? Eva Vacha Dentist Technische Universität München, Germany
Periprosthetic Joint Infections due to bacteria from the oral cavity What do we know? Eva Vacha Dentist Technische Universität München, Germany Background The risk of haematogenic prosthetic joint infection
More informationDiagnosis and Treatment of Respiratory Illness in Children and Adults
Page 1 of 9 Main Algorithm Annotations 1. Patient Reports Some Combination of Symptoms Patients may present for an appointment, call into a provider to schedule an appointment or nurse line presenting
More informationAXITAB-CV TAB. COMPOSITION :
AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil
More informationReceived 18 June 2004; returned 6 August 2004; revised 1 December 2004; accepted 8 December 2004
Journal of Antimicrobial Chemotherapy (2005) 55, 347 351 doi:10.1093/jac/dki013 Advance Access publication 4 February 2005 Concentrations and in vivo antibacterial activity of spiramycin and metronidazole
More informationORIGINAL ARTICLE SUSCEPTIBILITY PATTERNS IN GRAM NEGATIVE URINARY ISOLATES TO CIPROFLOXACIN, CO-TRIMOXAZOLE AND NITROFURANTOIN
SUSCEPTIBILITY PATTERNS IN GRAM NEGATIVE URINARY ISOLATES TO CIPROFLOXACIN, CO-TRIMOXAZOLE AND NITROFURANTOIN Anoop Sinha 1, Benny P V 2 HOW TO CITE THIS ARTICLE: Anoop Sinha, Benny PV. Susceptibility
More informationAerobic bacteria in the oral cavity of patients with removable dentures
86 Daniluk T, et al. Advances in Medical Sciences Vol. 51 2006 Suppl. 1 Aerobic bacteria in the oral cavity of patients with removable dentures Daniluk T 1, Fiedoruk K 1, Ściepuk M 1, Zaremba ML 1 *, Ro
More information